Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Huan Jing Ke Xue ; 43(11): 4888-4904, 2022 Nov 08.
Artículo en Zh | MEDLINE | ID: mdl-36437061

RESUMEN

Since the late 1970s, marine ecotoxicology began to sprout and develop in China. Based on the principles of dose-response relationships, some marine organisms are used in toxicity tests to evaluate the impact of marine pollutants on marine organisms and marine ecosystems. At the early stage, marine ecotoxicological research mainly focused on the bioaccumulation, biomagnification, and biodegradation of traditional pollutants such as heavy metals, radioactive elements, organotin, petroleum hydrocarbons, and pesticides, as well as their toxic effects on survival, growth, and other physiological indicators. With the development of Chinese industry, marine pollution has become increasingly serious. In addition to the traditional marine pollutants, toxicological research has been conducted on emerging pollutants with potential risks to marine ecosystems, such as POPs, emerging organic pollutants, nanomaterials, and microplastics. Moreover, the species of marine organisms used in toxicity testing have become more diverse. The selection of testing organisms is essential for evaluating toxicity correctly. The toxicity tests should be conducted on a variety of organisms from different trophic levels to ensure the comprehensive understanding of the impact of pollutants on marine ecosystems. The major types of marine organisms used in the toxicity testing include marine alga, protozoa, rotifera, annelida, mollusc, echinoderma, arthropoda, cephalopoda, and marine fish, which have been used in the toxicological studies of various marine pollutants. The outcome results can serve as the scientific basis for the ecological risk assessment of marine pollutants and the establishment of seawater quality criteria. It should be noted that the sensitivity of different testing organisms to different types of pollutants is quite diverse. Therefore, in addition to conducting a battery of tests on a variety of species which play important roles in marine ecosystems, elucidating the toxic mechanisms in different species is also important for marine ecotoxicological studies. The application of the above-mentioned organisms in marine ecotoxicology research in recent years is briefly reviewed here. Particularly, the six commonly used marine model species (Skeletonema costatum, Euplotes vannus, oysters, sea urchins, Tigriopus japonicus, and Oryzias melastigma) used in toxicity testing are introduced in detail.


Asunto(s)
Contaminantes Ambientales , Contaminantes Químicos del Agua , Animales , Ecotoxicología , Ecosistema , Plásticos , Contaminantes Químicos del Agua/toxicidad , Contaminantes Químicos del Agua/análisis , Pruebas de Toxicidad , Organismos Acuáticos
2.
Mater Sci Eng C Mater Biol Appl ; 96: 635-641, 2019 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-30606575

RESUMEN

Cisplatin is a highly effective antitumor drug, which can kill cancer cells by crossing-linking DNA and inhibiting transcription, but this process is limited by the combination of cisplatin and many endogenous nucleophiles, such as glutathione (GSH). Thus, when cisplatin enter cells, it is potentially vulnerable to cytoplasmic inactivation by GSH. To settle this bottleneck, we designed and synthesized a probe compound (Probe 1) and fabricated pH-responsed cisplatin, Probe 1-loaded lipid-polymer hybrid NanoParticles (CPNPs) using a single-step sonication method. Probe 1 can specifically bind to GSH, thus avoiding the combination of GSH and cisplatin, and enhancing the pharmacological activity of cisplatin. In vitro studies have suggested CPNPs, compared with cisplatin, loaded lipid-polymer hybrid NanoParticles CNPs (Not contain Probe 1), could efficiently kill MCF-7 human breast cancer cells and A549 human nonsmall lung cancer cell. Hence, the CPNPs provided a new idea for treating cancer.


Asunto(s)
Neoplasias de la Mama , Cisplatino , Glutatión/metabolismo , Neoplasias Pulmonares , Nanopartículas , Células A549 , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Cisplatino/química , Cisplatino/farmacocinética , Cisplatino/farmacología , Preparaciones de Acción Retardada/química , Preparaciones de Acción Retardada/farmacocinética , Preparaciones de Acción Retardada/farmacología , Femenino , Humanos , Neoplasias Pulmonares/tratamiento farmacológico , Neoplasias Pulmonares/metabolismo , Neoplasias Pulmonares/patología , Células MCF-7 , Sondas Moleculares/química , Sondas Moleculares/farmacocinética , Sondas Moleculares/farmacología , Nanopartículas/química , Nanopartículas/uso terapéutico
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA